Literature DB >> 28849619

Stated conclusion about industry funding is opposite to what the paper's data show: letter regarding 'Selective outcome reporting in obesity clinical trials: a cross-sectional review'.

D B Allison1, D M Thomas2.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28849619      PMCID： PMC5675789          DOI： 10.1111/cob.12214

Source DB:  PubMed          Journal:  Clin Obes        ISSN： 1758-8103


× No keyword cloud information.
  5 in total

1.  Randomized controlled trials with statistically nonsignificant results.

Authors:  David B Allison; Mark B Cope
Journal:  JAMA       Date:  2010-09-01       Impact factor: 56.272

Review 2.  Selective outcome reporting in obesity clinical trials: a cross-sectional review.

Authors:  J Rankin; A Ross; J Baker; M O'Brien; C Scheckel; M Vassar
Journal:  Clin Obes       Date:  2017-05-30

3.  Reproducibility: A tragedy of errors.

Authors:  David B Allison; Andrew W Brown; Brandon J George; Kathryn A Kaiser
Journal:  Nature       Date:  2016-02-04       Impact factor: 49.962

4.  White hat bias: examples of its presence in obesity research and a call for renewed commitment to faithfulness in research reporting.

Authors:  M B Cope; D B Allison
Journal:  Int J Obes (Lond)       Date:  2009-12-01       Impact factor: 5.095

5.  Prevalence of primary outcome changes in clinical trials registered on ClinicalTrials.gov: a cross-sectional study.

Authors:  Sreeram Ramagopalan; Andrew P Skingsley; Lahiru Handunnetthi; Michelle Klingel; Daniel Magnus; Julia Pakpoor; Ben Goldacre
Journal:  F1000Res       Date:  2014-03-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.